JPH08509467A - 細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用 - Google Patents

細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用

Info

Publication number
JPH08509467A
JPH08509467A JP6518792A JP51879294A JPH08509467A JP H08509467 A JPH08509467 A JP H08509467A JP 6518792 A JP6518792 A JP 6518792A JP 51879294 A JP51879294 A JP 51879294A JP H08509467 A JPH08509467 A JP H08509467A
Authority
JP
Japan
Prior art keywords
cells
human
helicobacter pylori
bacterial cells
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6518792A
Other languages
English (en)
Japanese (ja)
Inventor
ノルマーク，ヤーン・スタツフアン
フアールク，ペル
ボレーン，トーマス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK22293A external-priority patent/DK22293D0/da
Priority claimed from DK76093A external-priority patent/DK76093D0/da
Application filed by Individual filed Critical Individual
Publication of JPH08509467A publication Critical patent/JPH08509467A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP6518792A 1993-02-26 1994-02-25 細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用 Pending JPH08509467A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK0222/93 1993-02-26
DK22293A DK22293D0 (da) 1993-02-26 1993-02-26 Anvendelse af glycosider
DK0760/93 1993-06-25
DK76093A DK76093D0 (da) 1993-06-25 1993-06-25 Anvendelse af glycosider
PCT/IB1994/000023 WO1994018986A1 (fr) 1993-02-26 1994-02-25 Utilisation de glycosides oligosaccharidiques comme inhibiteurs de l'adherence bacterienne

Publications (1)

Publication Number Publication Date
JPH08509467A true JPH08509467A (ja) 1996-10-08

Family

ID=26063555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6518792A Pending JPH08509467A (ja) 1993-02-26 1994-02-25 細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用

Country Status (8)

Country Link
EP (1) EP0690717A1 (fr)
JP (1) JPH08509467A (fr)
CN (1) CN1121311A (fr)
AU (1) AU6042594A (fr)
CA (1) CA2157049A1 (fr)
HU (1) HU9502497D0 (fr)
NO (1) NO953281D0 (fr)
WO (1) WO1994018986A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014129363A (ja) * 2007-09-07 2014-07-10 Childrens Hospital Medical Center 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
JP2015527339A (ja) * 2012-07-30 2015-09-17 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク グリカン組成物、その製造方法および医薬としてのそれらの使用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
CN1229115C (zh) * 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
ATE429233T1 (de) * 2001-06-29 2009-05-15 Glykos Finland Oy Verwendung mindestens einer glycoinhibitor- substanz gegen infektionskrankheiten
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
US20050233307A1 (en) 2002-09-12 2005-10-20 Kyle Gee Site-specific labeling of affinity tags in fusion proteins
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
MY191538A (en) * 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
EP3288389A4 (fr) 2015-04-28 2018-10-10 Children's Hospital Medical Center Utilisation de compositions d'oligosaccharides pour améliorer la prise de poids
CN111436617B (zh) * 2020-05-12 2022-12-23 西北大学 基于牛血清白蛋白的岩藻糖拟糖蛋白在抑制惰性凝集杆菌方面的用途及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
AU4993893A (en) * 1992-07-31 1994-03-03 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014129363A (ja) * 2007-09-07 2014-07-10 Childrens Hospital Medical Center 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
JP2015527339A (ja) * 2012-07-30 2015-09-17 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク グリカン組成物、その製造方法および医薬としてのそれらの使用

Also Published As

Publication number Publication date
CA2157049A1 (fr) 1994-09-01
NO953281L (no) 1995-08-21
CN1121311A (zh) 1996-04-24
WO1994018986A1 (fr) 1994-09-01
EP0690717A1 (fr) 1996-01-10
AU6042594A (en) 1994-09-14
HU9502497D0 (en) 1995-10-30
NO953281D0 (no) 1995-08-21

Similar Documents

Publication Publication Date Title
Falk et al. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium.
JPH08509467A (ja) 細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用
Falk et al. Lectins are sensitive tools for defining the differentiation programs of mouse gut epithelial cell lineages
Schroten et al. Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction
Stapleton et al. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.
Cao et al. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study
Cooling Blood groups in infection and host susceptibility
Piller et al. Comparison of the carbohydrate‐binding specificities of seven N‐acetyl‐D‐galactosamine‐recognizing lectins
Doell et al. Studies of small intestine during development I. Distribution and activity of ß-galactosidase
Errico et al. O-glycosylation in Echinococcus granulosus: identification and characterization of the carcinoma-associated Tn antigen
US4851338A (en) Method for diagnosing the presence of bacteria
Kilcoyne et al. Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes
Turner et al. Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: evidence for two different mechanisms
US7871793B2 (en) Antimicrobial carbohydrates and methods of using same
Forstner et al. Clinical aspects of gastrointestinal mucus
Falk et al. Characterization of microbial host receptors
Sherman et al. Pilus-mediated interactions of the Escherichia coli strain RDEC-1 with mucosal glycoproteins in the small intestine of rabbits
Wennerås et al. Binding of the fibrillar CS3 adhesin of enterotoxigenic Escherichia coli to rabbit intestinal glycoproteins is competitively prevented by GalNAc beta 1-4Gal-containing glycoconjugates
EP1169044B1 (fr) Structures glucidiques de n-acetyl lactosamine fucosyle sialyle permettant d'inhiber l'adhesion bacterienne
Sanchez et al. Inhibition of adhesion of enterotoxigenic Escherichia coli cells expressing F17 fimbriae to small intestinal mucus and brush-border membranes of young calves
Balanzino et al. Interaction of cholera toxin and Escherichia coli heat-labile enterotoxin with glycoconjugates from rabbit intestinal brush border membranes: relationship with ABH blood group determinants
Hata et al. Bovine milk inhibits both adhesion of Helicobacter pylori to sulfatide and Helicobacter pylori-induced vacuolation of vero cells
Tsubokawa et al. A monoclonal antibody, PGM34, against 6‐sulfated blood‐group H type 2 antigen, on the carbohydrate moiety of mucin: Analysis of the epitope sequence and immunohistochemical study
Wadström et al. Sulfatides inhibit binding of Helicobacter pylori to the gastric cancer Kato III cell line
Kivela Characterization of galactose-containing glycoconjugates in the human retina: a lectin histochemical study